Please anonymize the following text: 



Record date: 2095-07-16

          

Transplant Surgery Admit Note
Surgical Attending: Dr. John Escamilla
Fellow:  Dr. Robert Ivy
Senior Resident:  Dr. Zachary Terrell								
Intern: Dr. Victor L. Bonilla
MRN: 0658969
Pt Name:  Fagan, Joanne
Date of admission:  7/16/95

RFA:  Living-related renal transplant (from sister)

HPI:  The patient is a 41 year old woman with ESRD 2/2 DM nephropathy here for living-related renal transplant this morning.  She continues to make urine and her disease has not been complicated by UTI or voiding dysfunction.  Her past medical history is significant for CV disease   she has had 3 cardiac stents placed since 2094 and suffered an ischemic stroke in 2089 for which she takes Plavix.   This morning, she denies fever, chills, N/V/D, SOB, dyspnea, burning on urination, or any other symptoms.  

PAST MEDICAL/SURGICAL HISTORY:

IDDM diagnosed 30 yrs ago
CAD: 8/94 stent to mid LAD, 9/94 restenosis of LAD    taxus sten to LADt, RCA stent 10/94
12/94: dyspnea    40% in-stent restenosis of LAD. RCA stent patent.    with Cypher stents (2) to RCA (prox and distal).
Recent TTE: EF 77%
Recent stress test: 8 mets, mild anterior ischemia
CVA of left PCA territory 2093. No residual. Rx with ASA, folate, niaspan
CKD 
HTN
High cholesterol
Diabetic retinopathy
Anemia

MEDICATIONS: 

Lasix 80 mg qday
Toprol 25 mg qam
Vytorin  5/40 mg qpm
Niaspan  1000 mg qpm
Folic Acid 1 mg qdayEpogen 10,000 U q Sunday
Vitamin B12 500 mg qam
Vitamin B6 100 mg qam
Colace prn
Isosorbide 30 mg qam
Insulin pump at 1U/hr ( = NPH 12 U qam as per Dr. Valenti)
Sodium bicarbonate 650 mg tid
Diovan 160 mg qd (held)
Norvasc 5 mg qd  (held)
Plavix 75 mg qd (held)
ASA 325 mg qd (held)

ALLERGIES:

NKDA/NKA

SOCIAL HISTORY:

seamstress, lives with parents (single).
Tobacco:  negative
EtOH:  negative
Other drugs:  

FAMILY HISTORY:  

Father: HTN 
Mother: HTN, hyperlipidemia 
Maternal grandmother: CVA in her 60's, CAD, HTN - deceased at age 70
Siblings: all alive and well- no DM, CAD, CVA

ROS:   As per HPI. 

PHYSICAL EXAM:

Gen:  appears well, in NAD
VS:   pending
HEENT:  NCAT, PERRLA, OC/OP clear, sclerae anicteric
Pulm:  CTAB
Cardiac:  RRR, no M/R/G
Abd:  soft, NT/ND, BS+
Ext:  WWP, no LE edema. 2+ DP/PT pulses

LABS:





U/A: negative

Serologies:

  CMV
NEG
  HBsAb
POS
  HBsAg
NEG
  HBcAb

  HCV
NEG
  EBV

  VZV

  HIV
NEG


IMAGING:

CXR:  clear


A/P:   41 year old woman with diabetic nephropathy-induced ESRD here this morning for living-related renal transplant from sister.  

Cellcept in the AM, no thymoglobulin
to the OR today 


Victor L. Bonilla, MD, PhD
Pager 76006






 

        </document>
        <document type="Transcript" number="2" page="5" date="2095-07-16">
            


Record date: 2095-07-16

          

Transplant Surgery Admit Note
Surgical Attending: Dr. John Escamilla
Fellow:  Dr. Robert Ivy
Senior Resident:  Dr. Zachary Terrell								
Intern: Dr. Victor L. Bonilla
MRN: 0658969
Pt Name:  Fagan, Joanne
Date of admission:  7/16/95

RFA:  Living-related renal transplant (from sister)

HPI:  The patient is a 41 year old woman with ESRD 2/2 DM nephropathy here for living-related renal transplant this morning.  She continues to make urine and her disease has not been complicated by UTI or voiding dysfunction.  Her past medical history is significant for CV disease   she has had 3 cardiac stents placed since 2094 and suffered an ischemic stroke in 2089 for which she takes Plavix.   This morning, she denies fever, chills, N/V/D, SOB, dyspnea, burning on urination, or any other symptoms.  

PAST MEDICAL/SURGICAL HISTORY:

IDDM diagnosed 30 yrs ago
CAD: 8/94 stent to mid LAD, 9/94 restenosis of LAD    taxus sten to LADt, RCA stent 10/94
12/94: dyspnea    40% in-stent restenosis of LAD. RCA stent patent.    with Cypher stents (2) to RCA (prox and distal).
Recent TTE: EF 77%
Recent stress test: 8 mets, mild anterior ischemia
CVA of left PCA territory 2093. No residual. Rx with ASA, folate, niaspan
CKD 
HTN
High cholesterol
Diabetic retinopathy
Anemia

MEDICATIONS: 

Lasix 80 mg qday
Toprol 25 mg qam
Vytorin  5/40 mg qpm
Niaspan  1000 mg qpm
Folic Acid 1 mg qdayEpogen 10,000 U q Sunday
Vitamin B12 500 mg qam
Vitamin B6 100 mg qam
Colace prn
Isosorbide 30 mg qam
Insulin pump at 1U/hr ( = NPH 12 U qam as per Dr. Valenti)
Sodium bicarbonate 650 mg tid
Diovan 160 mg qd (held)
Norvasc 5 mg qd  (held)
Plavix 75 mg qd (held)
ASA 325 mg qd (held)

ALLERGIES:

NKDA/NKA

SOCIAL HISTORY:
seamstress, lives with parents (single).
Tobacco:  negative
EtOH:  negative
Other drugs:  

FAMILY HISTORY:  

Father: HTN 
Mother: HTN, hyperlipidemia 
Maternal grandmother: CVA in her 60's, CAD, HTN - deceased at age 70
Siblings: all alive and well- no DM, CAD, CVA

ROS:   As per HPI. 

PHYSICAL EXAM:
Gen:  appears well, in NAD
VS:   pending
HEENT:  NCAT, PERRLA, OC/OP clear, sclerae anicteric
Pulm:  CTAB
Cardiac:  RRR, no M/R/G
Abd:  soft, NT/ND, BS+
Ext:  WWP, no LE edema. 2+ DP/PT pulses



LABS:

   Gen:  NAD
VS:   pending
   HEENT:  NCAT, PERRLA, OC/OP clear, sclerae anicteric
Pulm:  CTAB
Cardiac:  RRR, M/RN:   RM:   NAD, NCS:   PD:   M:   NAD:  NAD



Pulmon
 

Vitness:  PH





  PH. 



  Vita



  



   



   




   












 



P














M


























M
   



 


Medic	















 








18: 




	M


  

	





	



 

 


27

15
  

A, M
    
   


 2


April

    
  








 100
            (0


    


 



Amy


F



A
M
A


  


25 

  
   

     
	    
  
  

   
Dr










Dr.


  
   
.


301.

:

.
[1 and the [
182, 13. 1 day, a, 1
. 

[10
:
: 8. 
121:

:
:  : A.
: 
: (C
A

. 6 -  
   6

:
A (M
A:
: An (1 An
.
1

16
2242:10. A. :, the.
 ( 1. An D of C Date [:1. 0: 1
. An
. An, A: An: [F (M - An. An An An
 (1. (0
 An An C, An An 2 An An Anister 20 An An0 An.0 An (  -  (1 (.   (0.
.  - An::1.0:.0 and, a:.., :. - An An An, An An An An.	 An An An An C2 An
. Anine An, An. An (.  C An - P:. 1, Anient, 2. An, , S and. An. An ( Anister (
 An  B
111 An.1 (1 - An. An An, a-  (B
. 600. An C
- 00 C An An ( An An An An An An An An C 0 C An. An An, An An, An An An An. An  An An  An  C.  An in An Anified, anive An Anist-An ( Anified (.-M.. Anine An, An. An 0 (1  (1-1-1 a in, An C. [.. M. An with a (00-2,, 1. :, [,.,. An C. An An An: An (. An C (  and  An- an a, a a in: An An ( P.  a,  and - :. An C. An : :, a- An C in An: An-1:. An T -0., P in. [. - [ [ C in a ( An, I An C- I  ( : T An C An T. T ( (.- [ - I: - Anist - B-2 ( C An  An
 T An- I An  An ( An An (  I  H An. I. ( An An  R. - T C H - C (- An- C An An C0 (0- I- B20- An  An T L R T- T C- R C An R- I -- C I  C T -  - C H I C C C C in- C. ( P and- a- I [ I L- I V P (-0,- -1 a- -- P H. P - in in I in (- S -0 R0 - L- R T- C C I I I C I- (, I,- C in C- -1-0 and in   - C.- C in a C I -- I C R- I T C- F,- T R T L P -- L T-  -, R. in - in,. in,  R ( P  P.  a P R --  ( in,,- (, C, R0 T- L and  C, L, M T- M R,- B ( R, - R- - C, -, and T T R-- C C P C C C.  C- of P- of.. H a and P C C C T T - C  I - C. C a with C I and - I.  P C-0 C- H- P C- a -- - I C C a in -/ I --: 0- a-  A  0 T P T C L C C C C: C C, C- F,  C- C  C F. -  C C B R T C  L C I- I C L C R F C- C B I C  R- - C- C  R  - C- C C- S - F- L L1 L2 (1 ( H ( T T L C C, S R R1 C R1/ M-1 C-0 M. L0 -0- C C-1 I B a C C C.0 C0 C110/ B0 F C0 P B F C T C C P B a C B a a M a C P L C G C C C C T C C C. C- I MM, M M C M C B C M1 C0. C,  C. C C C, C C M,- B,. 1 C C, C C C-20-011 C M C C. T-  T- B, B of./ C- I M1 I - M C  B I C D C C C- C- P C/ - ( C - C-  C C. C M C, M.-1 M- M. C B. C C. 0 M- C,.. C C C. C C C C C B A C C ( V C  B V- M C M/  M C C C C- C M M V V C V a V. C- B V C a C a/ C0 C. P/1  C1 C0. M C V V a C/ C C C C  C C P    a a C. C a  C A C C C V 1 C C B- 0. V. M 2 C- C C D C0-0/ B C- C-  C C-  . A- 0- a-  a a C   C B A C  A C0 C B C12- a M C C C1 a A C C C M C V- M V ( V-2- V/ V- V - M V - V- V0 1 C C m C C0 C M P000 P P0 C M1 V C-  m -1  m - M ( 2 V   C/ -  m